Ardelyx
Tenapanor 5 mg BID
Chronic Idiopathic Constipation (CIC)
Countdown
234days
Phase 3 readout · Feb 26, 2027
What's at stake
Phase 3 trial results for Tenapanor 5 mg BID in Chronic Idiopathic Constipation (CIC) are due Feb 26, 2027. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· ClinicalTrials.gov
verified 15h ago
“CT.gov NCT07382167: Phase 3 trial, sponsor Ardelyx, drug Tenapanor 5 mg BID. Primary completion date 2027-02-26 (estimated).”